This VEGF-mediated response could be hindered in APP/PS1 mice and AD patients’ brain because VEGF has been shown to accumulate in insoluble Aβ plaques where it might be trapped (Yang et al., 2004; Ryu et al., 2009; Thomas et al., 2015; Martin et al., 2021). Here, APP is linked to Alzheimer disease.